DR Congo Ebola outbreak not yet a global ‘health emergency’, but strong response to disease vital – UN health experts
An emergency meeting of United Nations health experts said on Friday that the Ebola outbreak in north-west Democratic Republic of the Congo (DRC) – where cases of the deadly disease have been confirmed in an urban area – does not yet meet the criteria to be deemed a “public health emergency of international concern.”
Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment to counter the latest flare-up of the virus, health officials said on Tuesday, the first time it has been deployed against an active outbreak.
Following a two-day mission in the Democratic Republic of Congo, the Head of the World Health Organization (WHO) on Tuesday repeated his call for warring parties in conflict-riven North Kivu to stop fighting, and allow health teams access to areas affected by the recent Ebola outbreak in the region.
Officials are hoping a new treatment can help patients already infected with the deadly virus, as they continue a vaccination campaign to prevent it.
(MedPage Today) -- War, infected HCPs, and high population density provide challenges to containment
Professor Paul Hunter, of the University of East Anglia, admitted this poses ‘substantial’ problems for aid workers battling round-the-clock to contain the outbreak.
Fifty-seven cases of Ebola have been identified in the ongoing outbreak in the Democratic Republic of Congo, WHO said Tuesday.
Congo's health ministry says Ebola outbreak spreads to 2nd province in turbulent northeast
[Vanguard] Towards ending the series of outbreaks of Lassa fever, Monkeypox, yellow fever, cholera, meningitis, Ebola and other epidemic diseases in Nigeria, the Nigeria Centre for Disease Control, NCDC, and the Private Sector Health Alliance of Nigeria, PHN, have launched the Alliance for Epidemic Preparedness and Response, A4EPR.
Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment on patients in the east of the country, the health ministry said on Tuesday, the first time it has been deployed against an active outbreak.
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.